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Fig. 1. Patch test with lidocaine 1% pet, D3 +++ .
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Adverse reactions to lidocaine are
uncommon and allergy is rare (1). An
immediate type reaction to lidocaine
is seen more often than a type IV
allergy (2, 3).
Case Report
A 54-year-old woman developed a
severe perianal eczematous reaction
a few days after applying a lido-
caine cream for haemorrhoids. She had
used this cream approximately once a
year, without any problem. The general
practitioner prescribed TriAnal® (Will-
Pharma BV, Zwanenburg, The Nether-
lands) to treat the perianal dermatitis.
This worsened the dermatitis with bul-
lae, swelling, erosions, and extending
it to the genital region. An internal
cause was suspected and the patient
was referred to a proctologist after
the dermatitis resolved. She was exam-
ined twice, using Urogliss® (Montavit
Table 1. Patch test results of the local anaesthetics series
Allergen Concentration (%) Vehicle Day 3 Day 7
Benzocaine 5 Pet – –
Tetracaine hydrochloride 1 Pet – –
Procaine hydrochloride 1 Pet – –
Bupivacaine 2 Pet ++ +
Lidocaine 1 Pet +++ +++
Prilocaine hydrochloride 5 Pet – +
Articaine 2 Aqua – –
Dibucaine 5 Pet – –
Mepivacaine 2 Aqua ++ ++
Naropin 1 Aqua – –
Sodium metabisulﬁte 1 Pet – –
Triamcinolone acetonide 1 Alc – –
Pet, petrolatum; Alc, alcohol.
Pharma, Almelo, The Netherlands) as
a lubricant, and after 2 days she devel-
oped redness, itching, and blisters.
The patient was patch tested with
the European baseline series (TRUETM
test, Mekos, Hillerød, Denmark) and
a local anaesthetics series (Allergen
bank, VU University Medical Centre,
Amsterdam, The Netherlands) in Van-
der-Bend® square chambers (Brielle,
The Netherlands) on Fixomull® stretch
(BSN, Almere, The Netherlands), with
2D occlusion. Tests were read accord-
ing to the guidelines of the Inter-
national Contact Dermatitis Research
Group (ICDRG) on D3 and D7 (Table
1). The only positive reactions were to
lidocaine 1% (D3 +++ ,D 7+++ )
(Fig. 1), bupivacaine 2% (D3 ++,D 7
+), mepivacaine 2% (D3 ++,D 7++),
and prilocaine 5% (D3–, D7 +).
A provocation test with a 2-ml sub-
cutaneous injection of lidocaine 2%
showed erythema, swelling and vesi-
cles after 5 days (Fig. 2).
Discussion
We present a patient with a bul-
lous type IV allergy to lidocaine afterCONTACT POINTS 301
Fig. 2. Provocation test with subcutaneous injection of lidocaine 2%
from an ampoule, D5 bullous reaction.
a lidocaine cream for haemorrhoids.
In the literature, the use of anti-
haemorrhoidal preparations is the most
common sensitizer to lidocaine (1, 3).
The increased over-the-counter sale of
these preparations could account for
the rise of the number of cases pre-
senting with delayed-type IV allergy to
lidocaine (2).
Previously, our patient had received
injections of articaine from her dentist,
without experiencing any problems.
There was no further history of contact
with local anaesthetics. The relapse and
worsening of symptoms after sensiti-
zation can be explained by the use of
TriAnal® and Urogliss®.T r i A n a l ® is
an anti-haemorrhoidal cream contain-
ing triamcinolone acetonide and lido-
caine. Urogliss® is a lubricant con-
taining lidocaine, which is used during
proctological examinations.
In our patient, there is a cross-
reactivity with bupivacaine, mepiva-
caine and prilocaine. Cross-reactivity
with these amide-type anaesthetics has
often been reported (2). As suspected,
there was no cross-reactivity with an
ester-type anaesthetic (1). We veriﬁed
the positive patch test to lidocaine with
intradermal testing and provided our
patient with safe alternatives to use
in the future. The ﬁrst choice for any
future local anaesthesia used by her
dentist or other medical professionals
is the ester-type anaesthetic procaine.
If this is not available, articaine and
naropin would also be safe alternatives
for our patient.
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